Lutetium-177 Dotatate-Induced Hemolytic Anemia and Myelodysplastic Syndrome

Lutetium-177 ((177)Lu) dotatate is a type of peptide receptor radioligand therapy (PRRT) using radiolabeled somatostatin for patients with progressive somatostatin receptor-positive gastrointestinal neuroendocrine tumors. While cases of therapy-related myeloid neoplasms (t-MN) have been described as...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkassis, Samer, Ali, Mohammed, Awadelkarim, Abdalaziz M, Saad, Eltaib, Halboni, Adnan, Alhusain, Rashid, Kamatham, Saivaishnavi, Idris, Isra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938243/
https://www.ncbi.nlm.nih.gov/pubmed/35371754
http://dx.doi.org/10.7759/cureus.22392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938243/
https://www.ncbi.nlm.nih.gov/pubmed/35371754
http://dx.doi.org/10.7759/cureus.22392

Ejemplares similares